## Core Concept
Dantrolene sodium is a medication used to treat malignant hyperthermia and certain cases of spasticity. It acts directly on skeletal muscle to reduce muscle tone. The mechanism involves interference with calcium ion release from the sarcoplasmic reticulum.

## Why the Correct Answer is Right
Dantrolene sodium works by inhibiting **ryanodine receptors** on the sarcoplasmic reticulum, which are crucial for calcium ion release. By blocking these receptors, dantrolene decreases the amount of calcium ions available for muscle contraction, thereby reducing skeletal muscle tone. This action is specific to skeletal muscle and does not significantly affect smooth muscle or cardiac muscle.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because dantrolene's mechanism does not primarily involve blocking **acetylcholine receptors**. Acetylcholine receptor antagonists, like curare, work by preventing acetylcholine from binding to its receptors at the neuromuscular junction, which is a different mechanism.
- **Option B:** This option is incorrect as dantrolene does not act mainly by **inhibiting GABA receptors**. GABA (gamma-aminobutyric acid) receptors are involved in inhibitory neurotransmission in the brain, and their modulation affects neuronal excitability, not directly skeletal muscle tone.
- **Option C:** While **calcium channel blockers** do affect calcium ion movement, dantrolene's action is more specific to the intracellular release of calcium from the sarcoplasmic reticulum rather than blocking calcium influx through plasma membrane channels.

## Clinical Pearl / High-Yield Fact
A key point to remember is that dantrolene is specifically used for treating malignant hyperthermia, a life-threatening condition triggered by certain anesthetics. It is also used for spasticity management. A critical clinical correlation is that dantrolene can cause **hepatotoxicity**, necessitating monitoring of liver function tests in patients on long-term therapy.

## Correct Answer: D. Inhibiting ryanodine receptors.